Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

Sanofi has entered into an agreement to acquire Vigil Neuroscience Inc., a publicly traded clinical-stage biotechnology ...

The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...